Head-to-head comparison
Invyncible vs NuvaHealth
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Invyncible is a Florida telehealth platform pricing every GLP-1 dose program in the open, with all six of its compounding pharmacies named and patient-selectable.
From $149/mo (lowest dose rung) sema · From $180/mo (lowest dose rung) tirz · Verified August 2026
Marked down on: The entry price buys the smallest vial: the same plain semaglutide program runs $262.50 at 5 mg and $350 at 10 mg, which the FAQ confirms
Desk Score
NuvaHealth (nuvahealth.org) is a LegitScript-certified compounded GLP-1 telehealth platform offering compounded semaglutide starting at $159 first-month and compounded tirzepatide starting at $259 first-month.
$139/mo (first month only) sema · $229/mo (first month only) tirz · Verified July 2026
Marked down on: Standard ongoing monthly price NOT publicly disclosed (gated behind checkout) — patients should ask for the maintenance-dose price before committing
Invyncible takes this head-to-head with the higher Desk Score, 73/100 (C) against 69/100 (C) for NuvaHealth. NuvaHealth still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Invyncible
73/100
C
NuvaHealth
69/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Invyncible | NuvaHealth |
|---|---|---|
| Semaglutide | From $149/molowest dose rung$149/mo (0.45 mg dose, compounded with glycine + B12) | $139/mofirst month only$139/mo (first-month rate, compounded) |
| Tirzepatide | From $180/molowest dose rung$180/mo (2.5 mg weekly, 4-week program, compounded) | $229/mofirst month only$229/mo (first-month rate, compounded) |
| Coverage | 46 states plus DC | Not listed on NuvaHealth's site (checked July 2026) |
| Brand-name | Yes | Yes |
| Oral option | Yes | Yes |
| Best for | An open price list and a named, patient-selectable compounding pharmacy rather than an unnamed network. | Low first-month compounded GLP-1 pricing with 24/7 support. |
| Desk Score | 73/100C | 69/100C |
The verdict
Desk pick — InvyncibleInvyncible takes this head-to-head with the higher Desk Score, 73/100 (C) against 69/100 (C) for NuvaHealth. NuvaHealth still holds its ground where its strengths line up with yours.
Choose Invyncible if…
An open price list and a named, patient-selectable compounding pharmacy rather than an unnamed network.
From $149/mo (lowest dose rung) sema · From $180/mo (lowest dose rung) tirz · 46 states plus DC
Choose NuvaHealth if…
Low first-month compounded GLP-1 pricing with 24/7 support.
$139/mo (first month only) sema · $229/mo (first month only) tirz
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Invyncible · NuvaHealth.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Invyncible
- CoreAge Rx vs NuvaHealth
- Invyncible vs Ondra Health
- NuvaHealth vs Vaylen
- Invyncible vs Vaylen
- DoctorAdam vs NuvaHealth
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.